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Abstract: In this study, the residue depletion of sarafloxacin in black-bone silky fowl (BSF) was studied after oral doses of sarafloxacin (10
mg/kg BW for 7 consecutive days). Muscle and liver tissues were collected at differentwithdrawal periods and determined by HPLC-MS/
MS method. The limit of detection for sarafloxacin was 1.0 μg/kg, and the recoveries from blank fortified samples were 93.53%~108.47%
with coefficients of variation less than 9.28%. At first day after ending sarafloxacin treatment, the mean concentrations of sarafloxacin in
muscle and liver were 366.88 ± 129.51 and 120.35 ± 46.86 μg/kg, respectively, higher than their maximum residue limits (10 μg/kg for
muscle, 80 μg/kg for liver). Notably, the sarafloxacin concentrations in muscle depleted very slowlyand were still up to 45.46 ± 12.94 μg/
kg at 43.25 days after the last administration. Interestingly, the sarafloxacin concentrations in both tissues increased into peak values at
21 days. In addition, the withdrawal time of sarafloxacinin BSFs should be 93 days as calculated in this study, significantly longer than
that (0 day) in common broiler chickens. Therefore, our study provides data for a more prudent use of sarafloxacin in BSFs and suggests
a withdrawal time of 93 days was necessary to guarantee safety in BSFs for the consumers.
Key words: Sarafloxacin, residue depletion, withdrawal time, black-bone silky fowl

1. Introduction
Sarafloxacin (SAR) was the first fluoroquinolone (FQ)
antibacterial agent approved for use in poultry in the
United States, and was used for control the early mortality
in turkeys and broiler chickens [1]. However, the marketing
authorization of this drug in poultry has been withdrawn
in the USA owing to concerns about microbial resistance
[2]. Because SAR is the primarily metabolite of difloxacin,
a synthetic FQ highly effective for a wide variety of grampositive and gram-negative bacteria, it is still important to
monitor for the residues depletion of SAR in animals [3].
For monitoring the potentially unsafe residues to ensure the
safety of livestock products, several government authorities
have established the maximum residue limits (MRLs) and
withdrawal time of SAR. In the Republic of Korea, the
MRLs of SAR were established as 10~80 μg/kg for poultry.
In European, no MRLs have been set for SAR in chicken
kidney and muscle, because the predicted concentrations
in these tissues were below the limit of quantification, and
the MRL in liver was 100 μg/kg. In China, the MRLs for
chicken muscles and liver were established as 10 and 80
μg/kg, respectively. Importantly, SAR has been widely
used in chickens for fattening in China and the withdrawal

time of this drug in common broiler chickens was 0 day,
because the mean concentrations of SAR in muscle and
liver were both below their corresponding MRLs from
12h after administration of the last dose [4]. Up to date,
the depletion studies of SAR were reported in eel and eggs
[5–7]. The depletion residues of SAR in certain breeds
of chickens with large consumption were rarely studied,
although several detection methods for SAR, such as using
HPLC fluorometric, broad specific monoclonal antibody
and nanocomposite probe, in various types of animal
muscle have been reported [1, 8, 9].
Black-bone silky fowl (BSF, Gallus gallusdomesticus
Brisson) with black skin, muscle, and bones is a unique
breed of chicken originated from the south of China and
is distinguished from common broiler and layer chicken
according to the genome analysis [10]. BSF has some health
functions and can protect against a range of illnesses such
as treating diabetes and anemia, curing women’s diseases
like menoxenia and postpartum complications [11], thus,
consumption of such animals has increased over the recent
years. With the expansion of BSF breeding, the residues of
SAR in BSFs are emergent and there is a paucity of data
regarding the depletion of SAR in BSFs. Although the

* Correspondence: wens_yu86@163.com

470

This work is licensed under a Creative Commons Attribution 4.0 International License.

LIU et al. / Turk J Vet Anim Sci
residues depletion of SAR in common broiler chickens has
been studied using HPLC method [4], however, its limit
of detection (LOD) was high up to 50 μg/kg. In this study,
we aimed to evaluate the rate of depletion of SAR in edible
tissues (muscle and liver) of healthy BSFs using HPLCMS/MS method after repeat oral administration and a
withdrawal time of SAR in BSFs was also determined to
guarantee safety for the consumers.
2. Materials and methods
2.1. Animals
One hundred healthy BSFs (7 weeks old, half male and
half female) were provided by the Taihe Original BlackBone Silky Fowl Hennery (Guangdong, China). BSFs were
allowed a 7-day acclimation period prior to the study,
provided a drug-free pelleted dietand given water ad
libitum.
2.2. Chemicals and reagents
SAR hydrochloride (standard, 91.2%, Lot#G133594)
was purchased from Labor Dr. Ehrenstorfer-Schafers
(Augsburg, Germany) and SAR hydrochloride (10% soluble
powder, Lot#18040701) was donated by Henan Royal
Federation Biomedical Technology Co., Ltd. (Luoyang,
China). Enrofloxacin-d5 (ENR-d5) (hydrochloride salt
form, 99.0%) used as internal standard was purchased from
Sigma-Aldrich (St. Louis, MO, USA). All chromatographic
solvents used in this study were HPLC grade and the other
chemicals were analytical grade.
2.3. Drug application and sampling
All BSFs were placed in cages in the university animal
house. Five selected randomly were immediately sacrificed
and their muscle tissue was tested for SAR residues.
One hundred BSFs without SAR residue were randomly
divided into two groups and ten were in the same cage.
BSFs of group A (80 BSFs) were used to study tissue
depletion of SAR and were given serial daily doses of SAR
(10 mg/kg BW every 24 h for 7 consecutive days). BSFs
of group B (15) did not receive any treatment and were
used to determine the validation criteria of the analytical
method. All dosages were administered between 8 and 9
AM each day. The solutions for oral administration were
daily prepared by dissolving 10% SAR hydrochloride
soluble powder in sterilized bidistilled water. All BSFs were
weighed on the day of drug administration (at a dosage of
10 mg/kg b.w.). BSFs of group A were euthanized using
carbon dioxide at 1 d, 2 d, 3 d, 6 d, 9.25 d, 14.25 d, 21 d,
28 d, 36.25 d and 43.25 d after the last dose of SAR. Each
time point contained six BSFs and tissue specimens of liver
and muscle (breasts and legs) were sampled separately.
Each liver sample was minced and frozen at –45 ºC until
assayed for SAR concentrations. For the muscle tissue,
both breasts and legs of each individual wereminced and
mixed thoroughly before storing at –45 ºC.

2.4. Analytical method and validation
2.4.1. Tissue extraction
Extraction of SAR in tissue was performed as previously
described [12]. Tissue sample (4 g) and 16 mL of 5%
acetate-acetonitrile were added to a 50 mL polypropylene
centrifuge tube. Anhydrous sodium sulfate (4 g) and
sodium chloride (2 g) were then added in this tube,
followed by homogenizing for 1 min and centrifuging at
3155 g for 5 min. The supernatant was injected into a 50
mL tube with 400 mg C18 absorbent followed by 5 min
horizontal oscillation and centrifugation (3155 g for 5
min). Four milliliter of the organic layer was injected into
a 10 mL tube and was evaporated under nitrogen. The
residue was redissolved with 1 mL solution consisted of
0.1% formic acid aqueous solution and acetonitrile (9:1,
v/v) and then vortexed with 5 mL n-hexane saturated with
acetonitrile, followed by centrifugation at 3155 g for 10
min. The n-hexane layer was removed and the aqueous
solution was filtered with a 0.22 µm membrane filters for
analysis.
2.4.2. HPLC-MS/MS analysis
Liquid chromatography analysis was conducted on
UFLC-NEXERA system (LC-30AD, Shimadzu, Kyoto,
Japan). The chromatographic separation was performed
as previously described with slight modifications [12] and
was conducted on a 45 ºC waters BECH C18 column (50
mm × 2.1 mm, 1.7 μm). The mobile phase was consisted
of 0.1% formic acid aqueous solution (A) and methanol
solution containing 0.10% (v/v) formic acid (B). The
gradient elution was as follows: 95%–85% A for 2 min;
85%–60% A for 3 min; 60%–5% A for 2 min. Finally, the
gradient was set to 95% A for 2 min to allow equilibration.
The flow rate kept at 300 μL/min and an injection volume
of 10 μL was used.
Instrument AB Sciex QTRAP 5500 equipped with
ESI source in positive ion mode for mass spectrometric
detection was used. The transitions under the multiple
reaction monitoring (MRM) mode were of m/z
386.2→342.2 for SAR, and 365.0→321.3 for ENR-d5
(as internal standard), respectively. The shared mass
spectrometry parameters were 5500 V ion spray voltage,
550 ºC ion spray temperature, 30 psicurtain gas (CUR),
50 psi nebulizer gas (GS1) and 60 psi heater gas (GS2),
as previously described [12]. Table 1 contains the other
specific mass parameters for SAR and ENR-d5. The AB
Sciex Analyst software (version 1.6.3) was applied for
instrument control and original data processing.
2.4.3. Preparation of calibration curves
SAR was weighed accurately and dissolved in methanol
at 1 mg/mL, which was stepwise diluted with methanol
to obtain series of working solutions (40 ng/mL, 100 ng/
mL, 200 ng/mL, 400 ng/mL, 1000 ng/mL, 2000 ng/mL,
and 4000 ng/mL). The internal reference standard ENR-d5
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Table 1. Optimized mass parameters for sarafloxacin.
Analytes
Sarafloxacin
Enrofloxacin-d5

Precursor and product ion
Dwell time (ms)
(m/z)
386.2/342.2*
80

Declustering
potential (V)
80

Entrance
potential (ev)
25

386.2/299.2

80

80

38

365.0/321.3

80

80

26

was dissolved in methanol to obtain working solution of
500 ng/mL. Tissue samples without drugs were processed
as described in section 2.4.1, and corresponding working
solution of SAR was added into the 1 mL solution [0.1%
formic acid aqueous solution and acetonitrile (9:1, v/v)] to
obtain serials of final calibration standards 2 ng/mL, 5ng/
mL,10 ng/mL,20 ng/mL, 50 ng/mL, 100 ng/mL, and 200
ng/mL, respectively. The final concentration of ENR-d5 in
each standard was 25 ng/mL. The linearity was assessed
by plotting the peak area ratios ofthe SAR to the ENR-d5
against the concentrations of SAR within blank samples.
2.4.5. Method validation
Method validation parameters including recovery rate,
intraday precision, interday precision, limit of detection
(LOD), and limit of quantification (LOQ) were determined
as previously described [12]. For recovery rate, intra- and
interday precision, a set of six replicates (tissue samples)
added with SAR at three concentration levels (5, 10, and
20 μg/kg) and ENR-d5at 25 ng/mL, was used. Interday
precision was evaluated on 3 consecutive days. LOD and
LOQ for each analyte were calculated using the standard
deviation of six matrix blanks (sblank) and the slope of the
matrix-calibration (s): LOD = 3.3 × sblank/s LOQ = 10 ×
sblank/s[13].
3. Results
3.1. HPLC separation analysis
The typical MRM chromatograms were displayed in Figure
1. No endogenous interference was detected at the elution
times of SAR and ENR-d5, which were 4.66, and 4.28 min,
respectively. Carry-over was not observed.
3.2. Method validation results
As shown in Table 2, both the calibration curves of SAR in
muscle and liver samples showed good linearity over the
studied concentration ranges with correlation coefficients
(r2) > 0.9994. The representative calibration curves were f
= 0.01270 × C + 0.00342 for muscle, and f = 0.01018 × C
+ 0.04177 for liver, where f means the peak area ratio of
SAR to ENR-d5, and C is drug concentration. The linear
concentration range of SAR in the two tissues was both
from 2 μg/kg to 200 μg/kg.
Method validation results using the sample preparation
described in subsection 2.4 are summarized in Table
3. The recoveries of SAR from muscle and liver samples
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Retention
time (min)
4.74
4.35

were 93.53%~99.18% and 102.46%~108.47%, respectively.
Intraday precision for all tissue samples and spiked
concentration levels ranged from 1.52% to 5.09% and the
interday precision was less than 9.28% (Table 3). LOD for
SAR in spiked tissue samples was 1.0 μg/kg (S/N = 3) and
the corresponding LOQ was 5.0 μg/kg (S/N = 10). The
recoveries of SAR from both tissue samples at 5.0 μg/kg
spiked concentration level were more than 90%, with RSD
< 5.09% (Table 3), showing the LOQ was accurate.
3.3. Tissue residue depletion
Residues of SAR in tissues specimens after oral
administration of SAR (10 mg/kg BW, daily for
7 consecutive days) were determined. The tissue
concentration-time profiles for muscle and liver tissues
were presented in Table 4. Mean concentrations of SAR in
muscle and liver were 366.88 ± 129.51and 120.35 ± 46.86,
respectively at first day after ending SAR treatment (Table
4). The SAR concentrations depleted much slower from
the muscle tissue than liver tissue. SAR concentrations
in liver were below the MRL (80 μg/kg) since three days
after the end of treatment and depleted slowly. The SAR
concentrations in muscle samples decreased rapidly after
the last treatment, however, the concentration has been
increased since 9.25 days and decreased after 21 days. The
concentration of SAR in muscle at 43.25 days after the
administration was still 45.46 ± 12.94 μg/kg, which was
higher than the MRL (10 μg/kg) for muscle (Table 4 and
Figure 2).
3.4. Withdrawal time estimation
To calculate the withdrawal periods of SAR in the tissues
studied, linear regression analysis was performed using the
logarithmic transformed data and the withdrawal time was
determined as the time when the one-sided, 99% upper
tolerance limit of the regressi online with 95% confidence
level was below the MRL as previously described [14].
Based on the MRLs of SAR in liver (80 μg/kg) and muscle
(10 μg/kg),the withdrawal time for liver and muscle was
calculated as 20 days and 93 days, respectively, after oral
administration (10 mg/kg BW, daily for 7 consecutive
days) (Figure 3). Thus, the final withdrawal time in BSFs
should be 93 days.
4. Discussion
The pharmacokinetics of SAR has been described in
Atlantic salmon [15], Carassius auratus gibelio [16], pigs
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Figure 1. Typical MRM chromatograms of sarafloxacin and reference standard enrofloxacin-d5：(A) Blank chicken muscle; (B) Blank
chicken muscle added with enorfloxacin-d5; (C) Blank chicken muscle added with enorfloxacin d-5 and sarafloxacin (10 μg/kg); (D)
Chicken muscle sample after oral administration of sarafloxacin (10 mg/kg BW, daily for 7 days).
Table 2. Linear regression parameters of the calibration curves.
Samples

Calibration range (μg/ Standard calibration curve
kg)
Intercept Slope
R2

Muscle

2~200

0.00342

0.01270

Liver

2~200

0.04177

0.01018

Sarafloxacin residues in tissues (μg/kg)

0.9994

Time after
last dose (days)

0.9994

1.00

366.88 ± 129.51 120.35 ± 46.86

2.00

450.85 ± 336.30 71.87 ± 85.45

3.00

277.10 ± 104.21 35.06 ± 9.10

6.00

200.27 ± 96.18

35.55 ± 25.47

9.25

91.86 ± 42.29

16.95 ± 8.80

14.25

117.30 ± 62.56

8.63 ± 4.31

21.00

216.81 ± 59.87

13.10 ± 8.37

28.00

103.44 ± 36.06

7.61 ± 4.41

Table 3. Accuracy and precision for the analysis of sarafloxacin
in BSF muscle and liver tissues (n = 6).
Spiked
Intraday RSD Interday RSD
Samples level
Recovery (%)
(%)
(%)
(μg/kg)
Muscle

Liver

Table 4. Sarafloxacin residues in BSF tissues after a 7 day
medication period（n = 6, x ± s ）.

Muscle

Liver

5

99.18

4.28

7.79

10

93.53

3.52

4.01

20

94.49

1.69

2.30

5

108.47

5.09

9.28

36.25

82.68 ± 32.13

5.01 ± 3.05

10

104.06

4.51

7.89

43.25

45.46 ± 12.94

2.97 ± 1.58

20

102.46

1.52

3.95
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Figure 2. Depletion curves of sarafloxacin in different samples after cessation of sarafloxacin at 1, 2, 3, 6, 9.25, 14.25, 21, 28, 36.25 and
43.25 days.

Figure 3. Plot of the withdrawal time calculation for sarafloxacin in muscle and liver at the time when the one-sided 99% upper
tolerance limit is below the MRL for sarafloxacin (10 μg/kg for muscle, and 80 μg/kg for liver) after oral administration of sarafloxacin
(10 mg/kg BW, daily for 7 days).
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and chickens [17], however, the depletion of SAR was rarely
reported [4–7]. SAR has been widely used in chickens for
fattening and fishes in China, and therefore there is a great
need to study the residues depletion of SAR in BSFs, a
unique breed of chicken, with an increasing consumption
in China. Our results from the oral administrations of
SAR in BSFs showed that SAR had quite different residues
depletion characteristics compared to that in common
chickens.
In BSFs, the concentrations of SAR in muscle depleted
very slowly and its concentrations at 43.25 days after the
last administration were still 45.46 ± 12.94 μg/kg, which
was significantly higher than the MRL (10 μg/kg) for
muscle. However, the SAR concentrations in muscle of
broiler chickens were below the MRL (10μg/kg) since 12
h after administration of the last dose [4]. Interestingly,
the residues of ofloxacin in BSFs also depleted very slowly
and its concentrations in muscles were up to 193.5 μg/kg
at 40 days (longer than the withdrawn time of ofloxacin
in common chickens) after the last administration [18],
significantly higher than the MRL for common chicken
edible tissues (30 μg/kg) in the USA. This finding was
consistent with that of our study and both studies indicate
the FQs in BSFs have different depletion characteristics
when compared to common chickens. A unique feature
of BSF when compared with other common chickens is
the presence of melanosomes in various organs including
muscles, periosteum, trachea, mesentery, digestive canals,
ovary and testis [19,20], and the high level of melanin
might be the reason for the high residual concentrations of
FQs in muscles in our study because FQs have been proved
to bind with melanin through the basic nitrogenatom at
position 7 of the quinolone ring [21]. The affinities of
FQs for organs containing abundant melanin have been
reported in various fishes [22]. Actually besides FQs,
several drugs also had affinity to melanin [23], and melanin
had been proved to act as an adsorbent for drug residues
[24], resulting in the long term therapeutic/toxicological
activities [25]. For example, 35S-sulfadiazine and
14C-trimethoprim could combine with melanin, resulting
in high residual concentrations of these two drugs in the
organs containing abundant melanin in rainbow trout
[26].
The SAR concentrations in muscle and liver
samples decreased after the last treatment, however, the
concentrations in both tissues increased into peak values
at 21 days (Figure 2), presenting elimination curves
with two peaks in our study, which might because that
FQs were combined with melanin and glucuronic acid
in these tissues [24]. As the withdrawal time calculation
software (WT1.4) is designed to analyze data with firstorder kinetics [27], the four concentrations after 21 days

were selected to calculate the withdrawal time of SAR
and its withdrawal time in BSFs was 93 days, which was
significantly longer than that (0 day) in common broiler
chickens [4]. This finding suggest that species-to-species
extrapolation of the residue depletion of SAR in chickens
should be more prudent because the main parameters of
residue depletion of this drug varied in different chicken
species.
5. Conclusion
SAR has been widely used in chickens for fattening in
China, including BSFs (a unique breed of chicken in China)
which is consumed largely because of its high nutritional
and medicinal values. However, there is a paucity of data
regarding the depletion of SAR in BSFs. This paper first
reported the residue depletion of SAR in BSFs. Results
showed that SAR was eliminated slowly in vivo and its
concentration at 43.25 days after the last administration
in BSF muscle was still significantly higher than the
MRL (10 μg/kg) for muscle. In addition, the withdrawal
time of SAR in BSFs should be 93 days as calculated in
the current study, significantly longer than that (0 day) in
common broiler chickens. Therefore, our study provides
data for a more prudent use of SAR in BSFs and suggests
a withdrawal time after treatment in order to guarantee
safety in BSFs for the consumers.
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